Epistaxis resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords:

Overview

Epistaxis, also known as, noes bleeding, is a terminology name for bleeding of the nose vessels that drains out from nostril (most often) and/or nasopharynx. Epistaxis often stops easily but sometimes it's an ENT emergency which can be critical if appropriate action does not occur. Kiesselbach's plexus is the source of most epistaxis.

Causes

Base on the cause and severity of Epistaxis it can be life-threatening.

Life Threatening Causes

Life-threatening causes of epistaxis include conditions that may result in death or permanent disability within 24 hours if left untreated.

• Haemophilia
• Congestive heart failure
• Malignant hypertension

Common Causes

• Local trauma
• Acute sinusitis
• Allergic rhinitis
• Anticoagulation
• Aspirin
• Chronic rhinitis
• Chronic sinusitis
• Cocaine
• Common cold
• Foreign bodies
• Nose-picking
• Neoplasia

Diagnosis

Shown below is an algorithm summarizing the diagnosis of Epistaxis according to Epistaxis of Emergency Medicine Clinics of North America and Clinical Practice Nosebleed (Epistaxis) Guideline. This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.

Patient with Epistaxis? Take a complete medical history ❑ Recurrent bleeding? ❑ Using anticoagulant or antiplatelet medications? ❑ Recent trauma or surgery ❑ Vascular abnormalities ❑ Family history of epistaxis ❑ Allergies ❑ Cancer ❑ Other undelying diseases -Check the following labs in severe bleeding or with possibility of coagulopathy: ❑ CBC ❑ PT ❑ PTT

Trauma

Coagulopathy

Vascular abnormalities

Others

Trauma is the most cause of epistaxis(17%) ❑ Digital trauma ❑ Facial trauma ❑ Foreign body insertion ❑ Septal perforation ❑ Barotrauma ❑ Illicit drugs

❑Using Anticoagulants or Antiplatelet medications ❑ ITP* ❑ von Willebrand disease ❑ Leukemia ❑ Other medications cause coagulopathy

❑ HHT** ❑ Congestive heart failure ❑ Granulomatosis with polyangitis

❑Sinusitis ❑ Allergies ❑ Septal deviation ❑ Neoplasia in situ ❑ Renal failure ❑ Uremia ❑ Hepatic dysfuction ❑ Idiopathic ❑Infection

• ITP = Immune thrombocytopenic purpura
  • HHT = Hereditary Hemorrhagic Telangiectasia

This algorithm modified and developed according to Epistaxis of Emergency Medicine Clinics of North America and Clinical Practice Nosebleed (Epistaxis) Guideline, This guideline was published in January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.

Treatment

Shown below is an algorithm summarizing the treatment of [[Epistaxis]] according to The American Academy of ENT guidelines.

Statement Action Strength

Patient with Epistaxis

First assess ABC*

Need of Immediate Action?

Yes→ : ❑ Assess Airway ❑ Hemodynamic stability ❑ Needs for emergency setting

No

Active Bleeding ?

Yes→Nasal compression for≥5 min

No

Bleeding resume

Bleeding Controlled

Rhinoscopy to identify location of bleeding

Risk factor Assessment : ❑ Assess HHT** ❑ Bilateral bleeding ❑ Epistaxis history in Family

Bleeding site identified?

Rhinoscopy to identify location of bleeding

Yes→ Three options: ❑ 1=Lubricants ❑ 2=Topical vasoconstrictors ❑ 3=Nasal cautery

No

Bleeding site Identified

Bleeding site not identified

Decision for Nausal Cautery?

Anestesia bleeding site and limit Nasal cautery to site

Yes→ Anestesia bleeding site and limit Nasal Cautery to site

No

Bleeding controlled

Bleeding resume

Rist factor assessment

Suspected Bleeding site HHT** or Anticoagulants?

Patient education and prevention

NO→Non absorbable or Absorbable packing(Preferred in children)

Yes→Absorbable packing

Outcome Assesment

Nasal packing education

Discharge

Bleeding controlled

Bleeding resume

Patient use Anticoagulant or Antiplatelet medications

Patient doesn't use Anticoagulant or Antiplatelet medications

Patient Education and prevention

Life treatening Nose bleeding?

Outcome Assement

Yes→ Evaluate need for or risk of discontinuation Anti-Coag/Anti-Platelet medications

No

Discharge

Bleeding controled

Bleeding resume

Evaluate candidency for Embolization or Surgical arterial ligation

Appropriate intervention which may include Embolization, Surgery, Additional Nasal packing or Cautery

Patient Education and Prevention

Outcome Assesment

Discharge

• ABC= Airway, Breathing, Circulation
  • HHT= Hereditary Hemorrhagic Telangiecstasia

-This algorithm modified and developed according to Clinical Practice Nosebleed (Epistaxis) Guideline, This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.

Do's

• The content in this section is in bullet points.

Don'ts

• The content in this section is in bullet points.

References

Template:WikiDoc Sources